GENE ONLINE|News &
Opinion
Blog

Series A Funding
GentiBio Bags $157 Million in Series A to Fund Development of Treg Cell Therapies
2021-08-11
Singapore’s Esco Secures $200M in Oversubscribed Series A to Develop Cell and Gene Therapy Equipments
2021-05-28
With $41.9 Million from Oversubscribed Financing Round, XyloCor Sets Sights on Gene Therapy for Heart Disease
2021-03-23
Looking to Overcome Limitations in Gene Therapy Space, PBM Capital Backed Startup Launches with $20 M in Series A
2021-03-02
Jaguar Launches with a Pre-clinical Pipeline of AAV9-Based Gene Therapies
2021-02-28
Orna Therapeutics Brings to Market New Therapy to Treat Cancer and Other Diseases
2021-02-26
Ensoma Enters Gene-Editing Market with $70 Million Funding and Takeda Partnership
2021-02-12
Philadelphia Based Biopharma Raises $88 Million in Series A Financing
2021-01-07
Neuron23 Emerges from Stealth with $113.5 Million Financing
2020-12-18
Genesis Bags $52M Series A to Employ AI for Drug Discovery and Development
2020-12-06
Kinaset Therapeutics Debuts in the Asthma Market with $40 Million Financing
2020-12-02
D3 Bio Launches with $200 Million to Advance Precision Medicine in Oncology and Immunology Space
2020-11-22
Trailhead Biosystems Raises $6.6 Million in Series A Financing
2020-11-12
Scorpion Therapeutics Scores $108 Million Series A Funding for Oncological Research
2020-10-28
UK Startup Biofidelity Ltd. Acquires $12 Million in Series A Financing
2020-08-23
1 2 3
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top